Huang et al. reported that atorvastatin pretreatment can upregulate lncRNA H19 in MSCs and their secreted exosomes, which could be utilized for treating acute myocardial infarction in rats by inhibiting the inflammatory factors, along with increased release of VEGF and enhanced MSC-mediated cardioprotective effect [59]. The gene discussed is VEGFA; the disease is myocardial infarction.